Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Inflammation × Ketorolac × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 1 Pain 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Inflammation 1 Curative Breast Cancer Surgery 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Agnosia 1 Acute Pain 1

Interventions

Tea 1 Sufentanil 1 Morphine 1 Ketorolac 1 Ibuprofen 1 Anti-Inflammatory Agents, Non-Steroidal 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02141139 2014-05-19

Perioperative Inflammation and Breast Cancer Outcome

Samsung Medical Center

Phase 3 Unknown

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡